Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer
Status:
Withdrawn
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Peripheral stem cell transplantation may be able to replace immune cells that were
destroyed by chemotherapy and radiation therapy used to kill cancer cells. Sometimes the
transplanted cells can be rejected by the body's tissues. Mycophenolate mofetil, tacrolimus,
and donor white blood cells may prevent this from happening.
PURPOSE: Phase II trial to study the effectiveness of chemotherapy followed by peripheral
stem cell transplantation in treating patients who have metastatic or recurrent kidney
cancer.